@misc{indiciaec6dc5b90ae1b,
  title = {Pre-Clinical Blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma.},
  author = {Vincent-Fabert, C. and Roland, L. and Zimber-Strobl, U. and Feuillard, J. and Faumont, N.},
  year = {2018},
  doi = {10.1101/502922},
  url = {https://www.biorxiv.org/content/10.1101/502922v1},
  note = {Source identifier: 10.1101/502922}
}